Optura provides an enterprise platform that maps fragmented organizational data into a unified knowledge layer, scores and ranks AI use cases, simulates projected returns, and deploys and monitors AI agents across healthcare organizations. The ROAI™ discipline emphasizes measuring and tracking live performance against projected value to move organizations from experimentation to measurable outcomes. Optura reports more than $2 billion in AI initiatives on its platform, $120 million in tracked value, 700% ROAI™ on in-flight initiatives, and over 250 identified use cases. The company plans to invest the Series A proceeds in expanding AI capabilities, enlarging platform teams and scaling partnerships with large language model providers. Optura has commercial customers that include enterprise health plans and providers such as Independence Blue Cross, Prime Therapeutics and Ardent Health.

Total raised

$24M

Funding rounds

2

Latest round

Series A

Latest activity

May 2026